GCR has extensive experience in planning and implementing Phase I-IV programs for urology studies across multiple countries and sites.

Our global investigator network includes more than 1,000 urologists, nephrologists, internists and obstetricians / gynaecologists. Close working relationships with these investigators and sites ensure our ability to conduct a preliminary feasibility assessment quickly in order to predict enrolment and identify potential challenges for a viable protocol.


Urology Clinical Trial Experience

With global experience across multiple urology indications, we have conducted trials in recent years in the following:

  • Benign Prostatic Hyperplasia (BPH) / Lower Urinary Tract Symptoms (LUTS)
  • Erectile dysfunction
  • Kidney/renal disease
  • Osteoporosis
  • Overactive bladder
  • Premature ejaculation